Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Soquelitinib by Corvus Pharmaceuticals for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to...
Soquelitinib by Corvus Pharmaceuticals for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
Soquelitinib by Corvus Pharmaceuticals for T-Cell Lymphomas: Likelihood of Approval
Soquelitinib is under clinical development by Corvus Pharmaceuticals and currently in Phase II for T-Cell Lymphomas. According to GlobalData, Phase...